Back to Financial results
UNAUDITED FINANCIAL RESULTS
 
FOR THE  NINE MONTHS ENDED SEPTEMBER 30, 2008
        (Rupees in Lakhs.)
Particulars Three months ended 30.09.2008 Three months ended 30.09.2007 Corresponding  Six Months ended 30.09.2008 Corresponding  Six Months ended 30.09.2007 Year ended 31.3.2008
  Unaudited Unaudited Unaudited Unaudited Audited
1. (a) Net Sales 5301.48 4340.57 10404.93 8387.79 17567.15
    (b) Other Operating Income 1.34                   3.01 1.81              3.59 4.44
Total Operating Income 5302.82 4343.58 10406.74 8391.38 17571.59
           
2. Expenditure          
a) (Increase)/Decrease in stock 45.82 168.86 (130.76) (86.76) (435.01)
b)  Consumption of Materials 4651.06 3646.06 9123.68 7203.17 15283.14
c)  Purchase of Traded Goods 32.07                      -   32.07 30.8 30.69
d)  Employee Cost 106.46 101.58 210.11 194.1 441.04
e)  Depreciation 47.94 44.35 95.95 87.99 179.71
f)  Other expenditure 94.48 118.87 240.64 249.41 649.87
g) Total (a) to (f) 4977.83 4079.72 9571.69 7678.71 16149.44
           
3. Profit from Operation before other Income 324.99 263.86 835.05 712.67 1422.15
Interest & Exceptional items (1-2)          
4. Other Income 2.51                  3.32 5.33 5.32 15.22
           
5.Profit  before interst & Exceptional items (3+4) 327.50 267.18 840.38 717.99 1437.37
6. Interest 216.63 164.75 415.09 328.12 748.02
7. Profit after interst but before Exceptional items(5-6)              110.87               102.43            425.29          389.87                                    689.35
8. Execptional Items          
9. Profit from Ordinary activities before Tax (8-9) 110.87 102.43 425.29 389.87 689.35
10. Provision for Taxation          
       Income Tax(Including Fringe Benefit Tax) 10.00 13.27 40.00 40.00 147.23
        Earlier Years                     -                        -                    -                   -                                            -  
       Deferred Tax 15.09                (10.76)               6.42           (23.48) 29.11
       Wealth Tax                     -                        -                    -                   -   0.33
11. Profit from Ordinary activities after Tax 85.78 99.92 378.87 373.35 512.68
12.Extraordinary Items (net of tax expense)                     -                        -                    -                   -                                            -  
13.Net Profit for the Period 85.78 99.92 378.87 373.35 512.68
14.Paid-up Equity Share Capital 2600.50 2600.50 2600.50 2600.50 2600.50
 (face value Re.1/- per Share)          
15.Reserves excluding Revaluation Reserve                     -                        -                    -                   -   1881.86
Basic and Diluted Earnings Per Share before and after extraordinary Items (Rs.) 0.03 0.04 0.15 0.14 0.20
Public Shareholding          
Number of shares 194205340 194205340 194205340 194205340 194205340
Percentage of Shareholding 74.68% 74.68% 74.68% 74.68% 74.68%
Notes :          
1. The Company Operates only in one business segment namely formulaions.  
2.Previous period's figures have been regrouped/ rearranged wherever necessary to confirm to the current period's classification.
3. Provision for taxation for the Six months ended September 30, 2008 has been made on an estmate basis.  The actual tax 
    liability will be determined on the basis of the taxable income of the Company for the year from April 1, 2008 to March 31,2009
4. The above results were reviewd by the audit committee and taken on record of the meeting of the Board of Directors held on November 29, 2008
5. During the quarter 15 investor compliants were received and disposed off.  There were no investor compliants pending for redressal as at the commencement and end of the quarter
6. The above results for the quarter ended September30,2008 have been subjected to a  
    Limited Review by the Stuatory auditors  as per the listing agreement with the stock exchange  
 
Chennai - 600 084 For ARVIND REMEDIES LTD
Date:  November 29, 2008  
  DR.B.Arvind Shah  
      CEO & Managing Director  
Back to Financial results